Antibody Responses to Recombinant Epstein-Barr Virus Antigens in Nasopharyngeal Carcinoma Patients: Complementary Test of ZEBRA Protein and Early Antigens p54 and p138
Serological tests based on the antibodies directed against the Epstein-Barr virus early antigen (EA) and viral capsid antigen (VCA), which have been recognized as tumor markers for nasopharyngeal carcinoma (NPC), are routinely used to help in the diagnosis of this malignancy. The detection of these...
Збережено в:
| Опубліковано в:: | J Clin Microbiol |
|---|---|
| Автори: | , , , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
2001
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC88313/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11526145/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.39.9.3164-3170.2001 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|